Navigation Links
Mist over a way to help premature babies breathes cleared!

In a news study it has been shown that babies who were given an aid to help them breathe do not have the much feared consequences and is safe. The way was CNEP therapy - continuous negative-extrathoracic pressure. //

The theory was researched and assessed by unconnected Nottingham researchers to the original trial in the early 1990s.

This method was pioneered by controversial Stoke-based paediatrician Professor David Southall.

The Nottingham researchers followed up 133 of the 205 children still alive - now aged between nine and 15 - who were involved in the original CNEP study.

Half had the CNEP treatment - where pressure is applied to a child's chest to aid breathing. The rest were given the standard treatment of a breathing tube being inserted through the larynx - part of the windpipe.

No evidence was seen of a higher risk of long-term disabilities for children given CNEP.

“Our long-term study of the original trial participants suggests no evidence of disadvantage, in terms of long-term disability or psychological outcomes, from the use of CNEP," said the lead authors Professor Neil Marlow, of Queen's Medical Centre.

In a commentary piece in this week's Lancet, Professor Southall and Dr Martin Samuels, who also led the original CNEP study, welcomed the latest findings.

In their words, "We fear that over the last six years many infants with bronchiolitis a potentially fatal chest infection] presenting to our children's unit have received unnecessarily intensive care."
'"/>




Page: 1

Related medicine news :

1. Mothers with periodontitis may deliver premature babies
2. Death due to premature heartbeat after exercise
3. Women who conceive after a year have a higher chance of giving birth prematurely
4. Women who conceive after a year have a higher chance of giving birth prematurely
5. Gene is related to premature ageing disease
6. Drug for cancer may help restrict premature labor
7. India’s smallest premature baby brings immense joy to Indian parent
8. Brain development compromised in premature babies
9. New drug assists patients suffering premature ejaculation
10. How do babies understand language?
11. Test-tube babies show no emotional problems
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: